• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测 SARS-CoV-2 从大流行向地方病的转变:流行病学和免疫学方面的考虑。

Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations.

机构信息

Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America.

出版信息

PLoS Pathog. 2022 Jun 30;18(6):e1010591. doi: 10.1371/journal.ppat.1010591. eCollection 2022 Jun.

DOI:10.1371/journal.ppat.1010591
PMID:35771775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9246171/
Abstract

In this review, we discuss the epidemiological dynamics of different viral infections to project how the transition from a pandemic to endemic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) might take shape. Drawing from theories of disease invasion and transmission dynamics, waning immunity in the face of viral evolution and antigenic drift, and empirical data from influenza, dengue, and seasonal coronaviruses, we discuss the putative periodicity, severity, and age dynamics of SARS-CoV-2 as it becomes endemic. We review recent studies on SARS-CoV-2 epidemiology, immunology, and evolution that are particularly useful in projecting the transition to endemicity and highlight gaps that warrant further research.

摘要

在这篇综述中,我们讨论了不同病毒感染的流行病学动态,以预测从大流行向严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)流行的转变可能会如何形成。借鉴疾病入侵和传播动力学理论、面对病毒进化和抗原漂移时免疫力的减弱,以及流感、登革热和季节性冠状病毒的经验数据,我们讨论了 SARS-CoV-2 成为流行时的推测周期性、严重程度和年龄动态。我们回顾了最近关于 SARS-CoV-2 流行病学、免疫学和进化的研究,这些研究对于预测向流行的转变特别有用,并强调了需要进一步研究的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3a/9246171/c5e194cc7041/ppat.1010591.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3a/9246171/59cdf411bfd2/ppat.1010591.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3a/9246171/5948e836f760/ppat.1010591.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3a/9246171/c5e194cc7041/ppat.1010591.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3a/9246171/59cdf411bfd2/ppat.1010591.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3a/9246171/5948e836f760/ppat.1010591.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3a/9246171/c5e194cc7041/ppat.1010591.g003.jpg

相似文献

1
Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations.预测 SARS-CoV-2 从大流行向地方病的转变:流行病学和免疫学方面的考虑。
PLoS Pathog. 2022 Jun 30;18(6):e1010591. doi: 10.1371/journal.ppat.1010591. eCollection 2022 Jun.
2
After the pandemic: perspectives on the future trajectory of COVID-19.大流行之后:对 COVID-19 未来轨迹的展望。
Nature. 2021 Aug;596(7873):495-504. doi: 10.1038/s41586-021-03792-w. Epub 2021 Jul 8.
3
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.SARS-CoV-2 传播的独特特征:与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。
Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.
4
Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.SARS-CoV-2 的早期进化与跨冠状病毒免疫。
mSphere. 2020 Sep 2;5(5):e00622-20. doi: 10.1128/mSphere.00622-20.
5
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.具有有限的新冠病毒交叉反应性的季节性冠状病毒特异性B细胞在重症新冠病毒肺炎中主导IgG反应。
J Clin Invest. 2021 Nov 1;131(21). doi: 10.1172/JCI150613.
6
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.与季节性冠状病毒预先存在的免疫有关的 SARS-CoV-2 易感性增加和 COVID-19 严重程度的证据。
Cell Rep. 2021 Dec 28;37(13):110169. doi: 10.1016/j.celrep.2021.110169. Epub 2021 Dec 7.
7
The emergence of Covid-19: evolution from endemic to pandemic.Covid-19 的出现:从地方病到大流行的演变。
J Immunoassay Immunochem. 2022 Jan 2;43(1):22-32. doi: 10.1080/15321819.2021.1991947. Epub 2021 Oct 21.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
Dynamics of SARS-CoV-2 with waning immunity in the UK population.英国人群中免疫效力减弱的 SARS-CoV-2 动力学。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200274. doi: 10.1098/rstb.2020.0274. Epub 2021 May 31.
10
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.密歇根家庭流感疫苗评估(HIVE)队列中冠状病毒的发生:再感染频率和对季节性和严重急性呼吸综合征冠状病毒的血清学反应。
J Infect Dis. 2021 Jul 2;224(1):49-59. doi: 10.1093/infdis/jiab161.

引用本文的文献

1
The Challenge of Long COVID: Is the Pandemic Really Over?长新冠的挑战:疫情真的结束了吗?
Public Health Rep. 2025 Aug 17:333549251358665. doi: 10.1177/00333549251358665.
2
Real-time monitoring of excess mortality under a new endemic regime.新地方病流行态势下超额死亡率的实时监测
Euro Surveill. 2025 Jun;30(25). doi: 10.2807/1560-7917.ES.2025.30.25.2400753.
3
Epidemiological Analysis of the COVID-19 Clusters in the Early Stages of the Epidemic in Shanghai, China: Pandemic-to-Epidemic Response Shift.中国上海疫情早期新冠疫情聚集性病例的流行病学分析:从大流行应对到疫情应对的转变

本文引用的文献

1
Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination.SARS-CoV-2 Delta 和 Omicron 共感染和重组的证据。
Med. 2022 Dec 9;3(12):848-859.e4. doi: 10.1016/j.medj.2022.10.002. Epub 2022 Oct 20.
2
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations.SARS-CoV-2 感染引起的原始抗原性错误抗体水平高于 SARS-CoV-2 mRNA 疫苗接种。
Cell Rep. 2022 Oct 18;41(3):111496. doi: 10.1016/j.celrep.2022.111496.
3
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons.
Trop Med Infect Dis. 2025 Jun 17;10(6):170. doi: 10.3390/tropicalmed10060170.
4
Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants.异源初免-加强免疫接种可驱动基质激活和针对新冠病毒变异株的适应性免疫。
Front Immunol. 2025 May 28;16:1597417. doi: 10.3389/fimmu.2025.1597417. eCollection 2025.
5
Non-human primate seasonal transcriptome atlas reveals seasonal changes in physiology and diseases.非人灵长类动物季节性转录组图谱揭示了生理和疾病的季节性变化。
Nat Commun. 2025 Apr 28;16(1):3906. doi: 10.1038/s41467-025-57994-1.
6
Effects of Long-Term Air Pollution Exposure on Disease Outcomes and Hybrid Immune Responses in SARS-CoV-2 Breakthrough Infections: A Study of the Yichang COVID-19 Antibody Longitudinal Survey (YC-CALS) in China.长期暴露于空气污染对SARS-CoV-2突破性感染中疾病结局和混合免疫反应的影响:中国宜昌COVID-19抗体纵向调查(YC-CALS)研究
Environ Health Perspect. 2025 May;133(5):57022. doi: 10.1289/EHP15660. Epub 2025 May 27.
7
Causes and Consequences of Coronavirus Spike Protein Variability.冠状病毒刺突蛋白变异性的原因和后果。
Viruses. 2024 Jan 25;16(2):177. doi: 10.3390/v16020177.
8
Age-specific transmission dynamics of SARS-CoV-2 during the first 2 years of the pandemic.新冠疫情头两年期间新冠病毒的年龄特异性传播动态。
PNAS Nexus. 2024 Jan 31;3(2):pgae024. doi: 10.1093/pnasnexus/pgae024. eCollection 2024 Feb.
9
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines.对与新冠病毒变异株适配mRNA疫苗相关常见误解的回应。
Vaccines (Basel). 2024 Jan 6;12(1):57. doi: 10.3390/vaccines12010057.
10
Critical Needs for Integrated Surveillance: Wastewater-Based and Clinical Epidemiology in Evolving Scenarios with Lessons Learned from SARS-CoV-2.综合监测的关键需求:从 SARS-CoV-2 中吸取教训的不断变化的情景下的基于污水的和临床流行病学。
Food Environ Virol. 2024 Mar;16(1):38-49. doi: 10.1007/s12560-023-09573-0. Epub 2024 Jan 2.
奥密克戎变异株的快速出现与接种者中相对于德尔塔的感染优势有关。
Med. 2022 May 13;3(5):325-334.e4. doi: 10.1016/j.medj.2022.03.010. Epub 2022 Apr 6.
4
Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2.刺突蛋白 S1 中的快速且平行的适应性突变驱动 SARS-CoV-2 谱系成功。
Cell Host Microbe. 2022 Apr 13;30(4):545-555.e4. doi: 10.1016/j.chom.2022.03.018. Epub 2022 Mar 22.
5
Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function.选择分析鉴定出奥密克戎变异株 BA.1 中可能影响刺突功能的不寻常突变簇。
Mol Biol Evol. 2022 Apr 11;39(4). doi: 10.1093/molbev/msac061.
6
Assessing the risk of human-to-wildlife pathogen transmission for conservation and public health.评估人畜共患病原体传播对保护和公共卫生造成的风险。
Ecol Lett. 2022 Jun;25(6):1534-1549. doi: 10.1111/ele.14003. Epub 2022 Mar 22.
7
Strengthening global health security by improving disease surveillance in remote rural areas of low-income and middle-income countries.加强全球卫生安全,改善中低收入国家偏远农村地区的疾病监测。
Lancet Glob Health. 2022 Apr;10(4):e579-e584. doi: 10.1016/S2214-109X(22)00031-6.
8
Covid-19: Hong Kong reports world's highest death rate as zero covid strategy fails.新冠疫情:随着“动态清零”策略失败,香港报告全球最高死亡率。
BMJ. 2022 Mar 17;376:o707. doi: 10.1136/bmj.o707.
9
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.2020 - 2021年南非农村和城市地区严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的发病率、传播及再感染情况:PHIRST-C队列研究结果
Lancet Infect Dis. 2022 Jun;22(6):821-834. doi: 10.1016/S1473-3099(22)00069-X. Epub 2022 Mar 14.
10
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.